TherapeuticsMD, Inc. (TXMD) Current Reports & Earnings Releases
Upcoming
- 2026-11-12 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-11 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-30 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-21 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-12-16 | 8-K | Shareholder Vote Results | SEC |
| 2025-11-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-09 | 8-K | Other Events | SEC |
| 2025-03-27 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-05 | 8-K | Shareholder Vote Results | SEC |
| 2024-11-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-09-20 | 8-K | Item 5.08 | SEC |
| 2024-08-12 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-10 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-29 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.